Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.
Nomura Micro Science (TSE:6254) is back in focus after reporting steep FY2026 declines in sales and profits, while simultaneously lifting its dividend payout and issuing upbeat FY2027 guidance that points to a potential earnings recovery.
See our latest analysis for Nomura Micro Science.
The latest dividend increase and FY2027 guidance have arrived alongside a sharp shift in sentiment, with the stock posting a 1-day share price return of 13.66% and a 90-day share price return of 46.02%, while the 5-year total shareholder return is about 7x and recent momentum is strong.
If the recent jump in Nomura Micro Science has you looking at other beneficiaries of large scale infrastructure and equipment spending, this could be a good time to review the 35 power grid technology and infrastructure stocks .
With the share price already up sharply and management signaling a rebound through higher dividends and FY2027 guidance, the key question now is whether Nomura Micro Science is still undervalued or if the market has already priced in future growth.
Preferred P/E of 17.2x: Is it justified?
Nomura Micro Science is currently trading on a P/E of 17.2x, which leaves the stock looking relatively expensive compared both to peers and to its own fair P/E estimate.
The P/E ratio compares the share price with earnings per share, and it is a common way to see how much investors are paying for each unit of profit. For a company like Nomura Micro Science, which operates water treatment systems across sectors such as electronics and pharmaceuticals, this helps show how the market is valuing its earnings profile today.
According to the fair value work, the stock is described as good value versus an estimated fair P/E of 24.5x. This implies headroom if earnings track that framework. At the same time, the current 17.2x multiple is higher than the peer average of 16.5x and the broader JP Machinery industry on 14.6x, so the market is already paying a premium relative to sector benchmarks that could compress if sentiment or growth expectations cool.
That premium versus both direct peers and the industry is quite clear, and the fair P/E level offers a different reference point the market could gravitate toward over time.
Explore the SWS fair ratio for Nomura Micro Science
Result: Price-to-earnings of 17.2x (OVERVALUED)
However, the rich P/E and reliance on sectors like electronics and pharmaceuticals mean any slowdown in orders or delay in expected earnings could quickly pressure sentiment.
Find out about the key risks to this Nomura Micro Science narrative.
Another view: DCF points the other way
While the P/E discussion suggests some upside relative to a fair ratio of 24.5x, the SWS DCF model paints a very different picture. With the stock at ¥4,950 versus an estimated future cash flow value of ¥1,285.93, the DCF view frames Nomura Micro Science as overvalued. This raises the question of which signal you trust more.
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day ( check out Nomura Micro Science for example ). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 22 high quality undervalued stocks . If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
With mixed signals from valuation and sentiment, now is a good time to look through the numbers yourself and decide how the risk reward trade off stacks up in your view. You can start with the 2 key rewards and 2 important warning signs.
Looking for more investment ideas?
If Nomura Micro Science is already on your radar, do not stop here. Broaden your watchlist with other stocks that match your goals and risk comfort.
-
Target potential mispricing by scanning stocks that combine quality and value using the 22 high quality undervalued stocks .
-
Build a portfolio around income by reviewing stocks featured in the 37 dividend fortresses .
-
Dial down risk without stepping away from opportunities by filtering companies through the 56 resilient stocks with low risk scores .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include 6254.T .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
